Ninety-one percent of Americans consider the amount of plastic used in a product when making purchase decisions, and 45% believe producers – companies that...
Synaptogenix, Inc., an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, commented on the positive Phase 3 trial results for Lecanemab announced last...
Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia...
Tenchijin COMPASS is a web-based land evaluation application which analyzes characteristics and risks of various locations by using satellite data and AI. It supports...
